Tgf Beta Receptors
Tgf Beta Receptors - Related Videos
09:18
Spheroid Assay to Measure TGF-β-induced Invasion
0 Views •
Cited by 41 •
2011
An assay to quantitatively measure Transforming Growth Factor (TGF)-β-induced invasion in 3-dimensional collagen gels is described. This assay takes advantage of the MCF10A series of cell lines, which represent different stages of breast cancer development. This method can be adopted to be used with other cell lines and might be used to investigate other potential activators or inhibitors of invasion.
08:39
Affinity Labeling Detection of Endogenous Receptors from Zebrafish Embryos
0 Views •
Cited by 1 •
2016
A novel technique for the detection of low abundance endogenous receptors present in zebrafish embryos is described. We have named it AFLIP because it consists of affinity labeling of the receptor by its ligand linked to immunoprecipitation.
01:25
Beta
0 Views •
2024
Beta is a crucial metric in finance used to assess an investment's risk and expected return relative to the overall market. It is calculated as the slope of the line in a scatterplot that compares the returns of an individual stock to the returns of the market benchmark, typically represented by a broad market index. Beta quantifies how much a stock's price moves in response to market movements, providing insight into its volatility and systematic risk. A beta of one indicates that the stock's...
01:16
TGF - β Signaling Pathway
0 Views •
2023
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
09:50
In situ Quantification of Pancreatic Beta-cell Mass in Mice
0 Views •
Cited by 6 •
2010
The following protocol outlines the process of pancreatic dissection for virtual slice imaging, and the subsequent quantification of all GFP-tagged beta-cells in the entire pancreas.
FAQs
Type II receptors initiate the receptor complex after binding TGF-beta and then recruit type I receptors. The type II component phosphorylates the type I receptor, activating its signaling function. This ordered interaction ensures that ligand recognition is followed by kinase activation rather than occurring as disconnected receptor events, providing the entry point for downstream SMAD-dependent and SMAD-independent responses.
An activated type I receptor phosphorylates SMAD2 or SMAD3. These proteins then associate with SMAD4, forming a signaling complex that can regulate gene transcription. This sequence converts an extracellular ligand signal into changes in gene activity, allowing TGF-beta receptor signaling to influence longer-term cellular programs involved in development, tissue maintenance, and immune responses.
TGF-beta receptors can signal through pathways that do not rely on the SMAD2, SMAD3, and SMAD4 sequence. These SMAD-independent routes affect cell migration, proliferation, and survival, extending receptor influence beyond transcriptional regulation through the canonical pathway. Their contribution helps explain why receptor activation can produce several types of cellular behavior rather than a single uniform outcome.
TGF-beta receptor signaling regulates processes that are beneficial during normal tissue maintenance and repair but are also linked to disease processes when examined in pathological settings. Its effects on gene transcription, migration, proliferation, survival, and immune responses connect receptor activity with both tissue restoration and conditions such as fibrosis and cancer progression.
Studying these receptors helps researchers connect TGF-beta signaling with fibrosis, cancer progression, and immune regulation. The value lies in tracing how receptor-driven transcriptional and SMAD-independent responses alter cellular behavior in each setting. This biological context can clarify how the same signaling system participates in abnormal tissue changes, tumor-associated processes, or altered immune activity.
Receptor studies provide a framework for identifying signaling events that may be targeted therapeutically or monitored diagnostically. By relating receptor activation to downstream SMAD complexes, gene transcription, migration, proliferation, survival, and disease-associated outcomes, researchers can investigate which signaling features are most informative for developing targeted therapies and diagnostic strategies.